Truist Securities Reiterates Buy on UnitedHealth Group, Maintains $610 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald has reiterated a Buy rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $610.
November 30, 2023 | 7:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities analyst David Macdonald reaffirmed a Buy rating on UnitedHealth Group with a price target of $610.
The reiteration of a Buy rating and maintenance of a high price target by a reputable analyst like David Macdonald could instill confidence in investors and positively influence UnitedHealth Group's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100